Despite breakthroughs in interventional, pharmacological, and surgical therapy, organ failure remains the top cause of death worldwide. Since then, beyond human memory, bioartificial organ manufacturing has been a long-term goal. Man-made organs may, in the not-too-distant future, save the lives of people whose kidneys, pancreas, or lungs are failing. The design, modification, growth, and maintenance of living tissues implanted in natural or synthetic scaffolds to enable them to execute complicated biochemical activities, such as adaptive regulation and the replacement of regular living tissues, are all part of bioartificial organs. Healthy human cells (produced from organ tissue discarded during surgery) and biomaterials are used to construct bioartificial organs. A bioartificial kidney, for example, is constructed from kidney cells that have been cleverly linked to a ′membrane, ′ a porous capillary built from artificial polymer fibre. When human plasma is pushed via this tube, it reaches the kidney cells, which detect and eliminate toxins. In vitro, this bioartificial kidney can filter and cleanse blood, simulating the function of a real, healthy kidney. Future research will move away from the trial-and-error approach to implant optimization and toward the rational manufacturing of precisely formed nano biological devices.
Title : A revolution or surrender: The success and failures of tissue engineering and regenerative medicine
Thomas J Webster, Hebei University of Technology, China
Title : Open abdomen and negative pressure wound therapy for acute peritonitis especially in the presence of anastomoses and ostomies
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
Title : RNA activation in cancer and rare genetic diseases
Nagy Habib, Imperial College London, United Kingdom
Title : Light-based bioprinting: From bioink design to modulation of cell response in bioprinted hydrogels
Ruben F Pereira, University of Porto, Portugal
Title : Sandeep’s Procedure for Induction of Neo-angiogenesis (SPIN) for management of necrosis in tissue & impending gangrenes
Sandeep Shrivastava, Datta Meghe Institute of Medical Sciences, India
Title : Novel molecular mechanisms and therapeutic options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States